NCT06601218 2025-06-24
Impact of Daily Oral Cannabis Doses in Patients With Cancer
University of Kentucky
Phase 1 Recruiting
Clinical Trials
4 trialsNCT00674609 2023-05-03
SPRAY
Jazz Pharmaceuticals
Phase 3 Completed
NCT05272865 2023-02-01
Pharmacokinetic and Pharmacodynamic Evaluation of Formulations of Δ9-THC
LaSanta S A S
Phase 1/2 Unknown
NCT00316563 2010-02-09
Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study
AHS Cancer Control Alberta
Phase 2 Completed